Liquid biopsy for lung cancers: an update on recent developments

Area of Science:

• Oncology
• Genomics
• Molecular Diagnostics

Background:

• Liquid biopsy is an emerging technology in lung cancer care.
• It offers potential benefits for screening, early detection, monitoring, and prognostication.
• Established guidelines and expert recommendations support its clinical adoption in specific scenarios.

Purpose of the Study:

• To review the current data on various biomarkers used in liquid biopsy for lung cancer.
• To provide an overview of how these biomarkers are utilized in clinical practice.
• To highlight the evolving role of liquid biopsy in lung cancer management.

Main Methods:

• Review of existing literature and clinical data on liquid biopsy biomarkers in lung cancer.
• Analysis of biomarker performance and clinical utility.
• Synthesis of information regarding current adoption and future potential.

Main Results:

• Liquid biopsy offers valuable tumor genomic information.
• Several biomarkers are under active investigation for lung cancer applications.
• Specific clinical scenarios demonstrate the active adoption of liquid biopsy.

Conclusions:

• Liquid biopsy is a valuable complementary tool in lung cancer management.
• Understanding specific biomarkers is crucial for optimizing its clinical use.
• Continued research will further refine the application of liquid biopsy in lung cancer.